Cardiac Angiosarcoma from a Saphenous Vein Coronary Artery Bypass Graft

Pehr E Hartvigson1, Gautam R Velamoor2, Elizabeth T Loggers3

  • 1Radiation Oncology, University of Washington Medical Center, Seattle, USA.

Cureus
|November 1, 2019
PubMed

Insights

Primary cardiac angiosarcomas are rare with poor prognosis. This study reports the first cardiac angiosarcoma case originating from an autologous saphenous vein graft used in coronary artery bypass surgery.

Area of Science:

  • Cardiovascular Pathology
  • Surgical Oncology

Background:

  • Primary cardiac sarcomas (PCS) are rare malignancies with a generally poor prognosis.
  • Angiosarcoma is the most frequent histologic subtype of PCS, and its optimal management remains undefined.
  • Existing literature associates angiosarcomas with chronic lymphedema, foreign bodies (e.g., Dacron grafts), and arteriovenous fistulas.

Observation:

  • This report details the first documented instance of a cardiac angiosarcoma arising from an autologous saphenous vein graft.
  • The graft was utilized in a coronary artery bypass procedure.
  • The patient's clinical course and relevant literature are reviewed.

Findings:

  • The study presents a unique case of cardiac angiosarcoma with a specific origin in a coronary artery bypass graft.
  • This finding expands the known etiological associations of angiosarcoma.
  • The case highlights the potential for graft materials to serve as a substrate for tumor development.

Implications:

  • This case underscores the importance of considering graft materials in the differential diagnosis of cardiac tumors.
  • It may prompt further investigation into the long-term oncogenic potential of vascular grafts.
  • Understanding rare origins of cardiac angiosarcoma can inform diagnostic and therapeutic strategies for primary cardiac sarcomas.